Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Share-based Compensation (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Share-based Compensation readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 7.94% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.6 million, a 1.24% increase, with the full-year FY2025 number at $4.5 million, down 0.95% from a year prior.
  • Share-based Compensation hit $1.3 million in Q4 2025 for Lucid Diagnostics, up from $1.2 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.8 million in Q2 2022 to a low of $748000.0 in Q4 2023.
  • Median Share-based Compensation over the past 5 years was $1.3 million (2023), compared with a mean of $1.9 million.
  • Biggest five-year swings in Share-based Compensation: soared 339.38% in 2022 and later plummeted 71.32% in 2023.
  • Lucid Diagnostics' Share-based Compensation stood at $3.4 million in 2021, then decreased by 24.25% to $2.6 million in 2022, then plummeted by 71.32% to $748000.0 in 2023, then skyrocketed by 56.55% to $1.2 million in 2024, then increased by 7.94% to $1.3 million in 2025.
  • The last three reported values for Share-based Compensation were $1.3 million (Q4 2025), $1.2 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.